BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37604607)

  • 1. Capillary flow-driven immunoassay platform for COVID-19 antigen diagnostics.
    Link JS; Carrell CS; Jang I; Barstis EJO; Call ZD; Bellows RA; O'Donnell-Sloan JJ; Terry JS; Anderson LBR; Panraksa Y; Geiss BJ; Dandy DS; Henry CS
    Anal Chim Acta; 2023 Oct; 1277():341634. PubMed ID: 37604607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary driven microfluidic sequential flow device for point-of-need ELISA: COVID-19 serology testing.
    Carrell C; Jang I; Link J; Terry JS; Call Z; Panraksa Y; Chailapakul O; Dandy DS; Geiss BJ; Henry CS
    Anal Methods; 2023 Jun; 15(22):2721-2728. PubMed ID: 37099406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexed Capillary-Flow Driven Immunoassay for Respiratory Illnesses.
    Link JS; O'Donnell-Sloan J; Curdts S; Geiss BJ; Dandy DS; Henry CS
    Anal Chem; 2024 Mar; 96(10):4111-4119. PubMed ID: 38417100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrochemical Capillary-Flow Immunoassay for Detecting Anti-SARS-CoV-2 Nucleocapsid Protein Antibodies at the Point of Care.
    Samper IC; Sánchez-Cano A; Khamcharoen W; Jang I; Siangproh W; Baldrich E; Geiss BJ; Dandy DS; Henry CS
    ACS Sens; 2021 Nov; 6(11):4067-4075. PubMed ID: 34694794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of automated microfluidic immunoassays for the detection of SARS-CoV-2 antibodies and antigen.
    Johnson L; Bartlett ML; Ramirez F; Heger CD; Smith DR
    J Immunol Methods; 2024 Jan; 524():113586. PubMed ID: 38040191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gravity-Driven Microfluidic Siphons: Fluidic Characterization and Application to Quantitative Immunoassays.
    Reis NM; Needs SH; Jegouic SM; Gill KK; Sirivisoot S; Howard S; Kempe J; Bola S; Al-Hakeem K; Jones IM; Prommool T; Luangaram P; Avirutnan P; Puttikhunt C; Edwards AD
    ACS Sens; 2021 Dec; 6(12):4338-4348. PubMed ID: 34854666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents.
    Grant BD; Anderson CE; Williford JR; Alonzo LF; Glukhova VA; Boyle DS; Weigl BH; Nichols KP
    Anal Chem; 2020 Aug; 92(16):11305-11309. PubMed ID: 32605363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
    Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
    Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated Development of a COVID-19 Lateral Flow Test in an Academic Setting: Lessons Learned.
    Kourentzi K; Brosamer K; Vu B; Willson RC
    Acc Chem Res; 2024 May; 57(9):1372-1383. PubMed ID: 38590049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portable high-throughput multimodal immunoassay platform for rapid on-site COVID-19 diagnostics.
    Shan Y; Wang B; Huang H; Yan K; Li W; Wang S; Liu F
    Anal Chim Acta; 2023 Jan; 1238():340634. PubMed ID: 36464448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitive SARS-CoV-2 salivary antibody assays for clinical saline gargle samples using smartphone-based competitive particle immunoassay platforms.
    Liang Y; Buchanan BC; Khanthaphixay B; Zhou A; Quirk G; Worobey M; Yoon JY
    Biosens Bioelectron; 2023 Jun; 229():115221. PubMed ID: 36958205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fully Automated Chemiluminescence Microarray Analysis Platform for Rapid and Multiplexed SARS-CoV-2 Serodiagnostics.
    Klüpfel J; Paßreiter S; Weidlein N; Knopp M; Ungerer M; Protzer U; Knolle P; Hayden O; Elsner M; Seidel M
    Anal Chem; 2022 Feb; 94(6):2855-2864. PubMed ID: 35107016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of two SARS-CoV-2 IgG/IgM Rapid Tests in Capillary Blood Samples.
    Lee NY; Ham JY; Hwang N; Song KE
    Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study.
    Pallett SJC; Rayment M; Patel A; Fitzgerald-Smith SAM; Denny SJ; Charani E; Mai AL; Gilmour KC; Hatcher J; Scott C; Randell P; Mughal N; Jones R; Moore LSP; Davies GW
    Lancet Respir Med; 2020 Sep; 8(9):885-894. PubMed ID: 32717210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertical Flow Immunoassay Based on Carbon Black Nanoparticles for the Detection of IgG against SARS-CoV-2 Spike Protein in Human Serum: Proof-of-Concept.
    Kropaneva M; Khramtsov P; Bochkova M; Lazarev S; Kiselkov D; Rayev M
    Biosensors (Basel); 2023 Aug; 13(9):. PubMed ID: 37754091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
    Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
    Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lateral Flow Immunoassay of SARS-CoV-2 Antigen with SERS-Based Registration: Development and Comparison with Traditional Immunoassays.
    Serebrennikova KV; Byzova NA; Zherdev AV; Khlebtsov NG; Khlebtsov BN; Biketov SF; Dzantiev BB
    Biosensors (Basel); 2021 Dec; 11(12):. PubMed ID: 34940267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of diagnostic accuracy of 10 serological assays for detection of SARS-CoV-2 antibodies.
    Gutiérrez-Cobos A; Gómez de Frutos S; Domingo García D; Navarro Lara E; Yarci Carrión A; Fontán García-Rodrigo L; Fraile Torres AM; Cardeñoso Domingo L
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):955-961. PubMed ID: 33236268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve lateral flow immunoassays (LFAs) to detect SARS-CoV-2 antibodies.
    Owen SI; Williams CT; Garrod G; Fraser AJ; Menzies S; Baldwin L; Brown L; Byrne RL; Collins AM; Cubas-Atienzar AI; de Vos M; Edwards T; Escadafal C; Ferreira DM; Fletcher T; Hyder-Wright A; Kay GA; Kontogianni K; Mason J; Mitsi E; Planche T; Sacks JA; Taylor J; Todd S; Tully C; Cuevas LE; Adams ER
    J Infect; 2022 Mar; 84(3):355-360. PubMed ID: 34906597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a rapid and easy-to-perform point-of-care lateral flow immunoassay (LFIA) for the detection of SARS-CoV-2 spike protein.
    Mohammad S; Wang Y; Cordero J; Watson C; Molestina R; Rashid S; Bradford R
    Front Immunol; 2023; 14():1111644. PubMed ID: 36911726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.